ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08955
0,26%
Bitcoin
66.768,75
2,34%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Omrix Biopharmaceuticals (MM) (OMRI)

  7. Omrix Biopharmaceuticals (MM) (OMRI) News

OMRI

Omrix Biopharmaceuticals (MM) (OMRI)

Omrix Biopharmaceuticals (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:OMRI
DatumZeitQuelleÜberschriftSymbolFirma
30/12/200823h21Edgar (US Regulatory)(25-NSE)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
30/12/200822h59Edgar (US Regulatory)Notice of Termination of a Foreign Private Issuer's Registration of a Class of Securities under Section 12(g) (15F-12G)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
30/12/200821h34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
29/12/200815h57MarketwiredBridgewaterEquity.com Free Fundamental Sector & Market Research on BEBE, OMRI, SONS and CALMNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
29/12/200812h27Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
27/12/200816h08PR Newswire (US)Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
19/12/200823h42PR Newswire (US)Johnson & Johnson Extends Tender Offer for Omrix Biopharmaceuticals, Inc.NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
19/12/200823h00Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
19/12/200822h49Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
19/12/200812h02Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
18/12/200822h02Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
17/12/200823h24Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
17/12/200823h03Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
17/12/200812h04Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/12/200821h38Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
11/12/200823h40PR Newswire (US)Johnson & Johnson Announces Receipt of Israeli Antitrust Approval for Acquisition of OmrixNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
05/12/200822h52Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
03/12/200819h45MarketwiredLaw Offices of Brian M. Felgoise, P.C. Announces Class Action Lawsuit on Behalf of Shareholders of Omrix Biopharmaceuticals, IncNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
01/12/200823h30Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
01/12/200823h25Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
26/11/200812h01Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
25/11/200823h12Edgar (US Regulatory)Current report filing (8-K)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
25/11/200819h10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
25/11/200818h43Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
25/11/200818h38PR Newswire (US)Johnson & Johnson Begins Tender Offer to Acquire OmrixNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
24/11/200823h06Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
24/11/200812h30PR Newswire (US)Johnson & Johnson Announces Definitive Agreement to Acquire OmrixNASDAQ:OMRI
21/11/200817h03Edgar (US Regulatory)Current report filing (8-K)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
10/11/200817h25Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
06/11/200819h47Business WireOmrix Biopharmaceuticals to Webcast Presentation at Credit Suisse Annual Healthcare ConferenceNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:OMRI

Kürzlich von Ihnen besucht

TSXV
NXT.H
Natcore Technology
TSXV
ENP
Enpar Technologies Inc.
HITB
DIMETH
DIMCOIN
COIN
DARRETH
LATK
OTHRUSDT
OtherDAO
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten